Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/143370
Full metadata record
DC FieldValueLanguage
dc.creatorMonteiro, A
dc.creatorVelon, AG
dc.creatorRodrigues, AM
dc.creatorOliveira, A
dc.creatorValadas, A
dc.creatorNóbrega, C
dc.creatorCruto, C
dc.creatorNeutel, D
dc.creatorSimões do Couto F
dc.creatorMorgado J
dc.creatorCerejeira, J
dc.creatorRuano, L
dc.creatorGago, M
dc.creatorGrunho, M
dc.creatorTábuas-Pereira, M
dc.creatorTaipa, R
dc.creatorMoiron Simões, R
dc.creatorAraújo, R
dc.creatorBarreto, R
dc.creatorRocha, S
dc.creatorMassano, J
dc.date.accessioned2022-08-23T15:11:59Z-
dc.date.available2022-08-23T15:11:59Z-
dc.date.issued2020
dc.identifier.issn1646-0758
dc.identifier.urihttps://hdl.handle.net/10216/143370-
dc.description.abstractLewy body dementia is a common cause of dementia leading to the progressive deterioration of cognitive function and motor skills, behavioral changes, and loss of autonomy, impairing the quality of life of patients and their families. Even though it is the second leading cause of neurodegenerative dementia, diagnosis is still challenging, due to its heterogenous clinical presentation, especially in the early stages of the disease. Accordingly, Lewy body dementia is often misdiagnosed and clinically mismanaged. The lack of diagnostic accuracy has important implications for patients, given their increased susceptibility to the adverse effects of certain drugs, such as antipsychotics, which may worsen some symptoms associated with Lewy body dementia. Therefore, a specialist consensus based on the analysis of the most updated and relevant literature, and on clinical experience, is useful to all professionals involved in the care of these patients. This work aims to inform and provide recommendations about the best diagnostic and therapeutic approaches in Lewy body dementia in Portugal. Moreover, we suggest some strategies in order to raise the awareness of physicians, policy makers, and the society at large regarding this disease.
dc.description.sponsorshipEste trabalho foi parcialmente financiado pela GE Healthcare Espanha para apoio à logística da realização da reunião de consenso e para apoio de medical writing no âmbito da preparação deste artigo. A GE Healthcare Espanha não teve qualquer papel no desenho do consenso, recolha, análise e interpretação de literatura, redação do manuscrito, nem na decisão de submeter o artigo para publicação. As opiniões expressas no artigo são da responsabilidade dos autores e não são necessariamente as da GE Healthcare Espanha.
dc.language.isopor
dc.publisherOrdem dos Médicos
dc.relation.ispartofActa Med Port. 2020 Dec 2;33(12):844-854
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectConsensus
dc.subjectDementia/diagnosis
dc.subjectDementia/therapy
dc.subjectLewy Body Disease/diagnosis
dc.subjectLewy Body Disease/therapy
dc.subjectPortugal
dc.titlePortuguese Consensus on the Diagnosis and Management of Lewy Body Dementia (PORTUCALE)
dc.typeArtigo em Revista Científica Nacional
dc.contributor.uportoInstituto de Saúde Pública da Universidade do Porto
dc.identifier.doi10.20344/amp.13696
dc.relation.publisherversionhttps://actamedicaportuguesa.com/revista/index.php/amp/article/view/13696/6204
Appears in Collections:ISPUP - Artigo em Revista Científica Nacional

Files in This Item:
File Description SizeFormat 
monteiro-amp-2020.pdf444.09 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons